Marti-Macia C, Tomasa TM, Sancho A, Galán A, Fernández-Llamazares J, Macias V, Roca J, Gonzalez-Celador R, Amestoy É, Klamburg J. [Analysis of neutrophil gelatinase-associated lipocalin in the critical patient].
Med Intensiva 2013;
38:146-53. [PMID:
23827694 DOI:
10.1016/j.medin.2013.03.014]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2012] [Revised: 03/11/2013] [Accepted: 03/31/2013] [Indexed: 01/19/2023]
Abstract
OBJECTIVE
To determine if NGAL value exceeding 150 ng/mL is a good diagnostic test for acute renal failure in critically ill patients.
DESIGN
Prospective, observational cohort.
SETTING
Intensive Care Unit and Cardiac Surgery Intensive Care Service at Hospital Germans Trias I Pujol.
PARTICIPANTS
Patients admitted to the Intensive Care department the Designated days in the studio.
INTERVENTIONS
Analysis of serum creatinine blood given from 7 days prior to the start of the study, and daily during 4 weeks and by determination of NGAL urine test in frozen sample, analyzer ARCHITECT (Abbott Diagnostics) determined by immunoassay the day baseline and 2 times a week for 4 weeks, analysis of the stay and mortality.
RESULTS
A total of 529 NGAL samples were obtained from 46 patients. 37% of patients had a value of NGAL>150 ng/mL. The Sensivity of the test to diagnose acute renal failure was 69%, Specifity was 75,7%. However, the Positive Predictive Test Value was 53%, which means that 47% of patients with high NGAL did not develop AKI. A NGAL >150 mg/dL was associated with a significantly higher SOFA and a longer stay in the ICU. The mortality of patients with elevated NGAL was 58.8%.
CONCLUSIONS
A NGAL>150 ng/mL does not seem to be an excellent test for AKI in critically ill patients but is associated with a worse prognosis.
Collapse